Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 409

1.

Endoscopic ultrasonography-guided transmural drainage of an infected hepatic cyst due to Edwardsiella tarda: a case report.

Taguchi H, Tamai T, Numata M, Maeda H, Ohshige A, Iwaya H, Hashimoto S, Kanmura S, Funakawa K, Fujita H, Ido A, Tsubouchi H.

Clin J Gastroenterol. 2014 Oct;7(5):422-8. doi: 10.1007/s12328-014-0520-4. Epub 2014 Sep 9.

PMID:
26184023
2.

Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan.

Fujiwara K, Yokosuka O, Inoue K, Yasui S, Abe R, Oda S, Arata S, Takikawa Y, Ido A, Mochida S, Tsubouchi H, Takikawa H; Intractable Hepato-Biliary Disease Study Group of Japan.

Hepatol Res. 2015 Jun 19. doi: 10.1111/hepr.12543. [Epub ahead of print] No abstract available.

PMID:
26096326
3.

Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013.

Onji M, Zeniya M, Yamamoto K, Tsubouchi H.

Hepatol Res. 2014 Apr;44(4):368-70. doi: 10.1111/hepr.12300. No abstract available.

PMID:
25989393
4.

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Watanabe S, Hashimoto E, Ikejima K, Uto H, Ono M, Sumida Y, Seike M, Takei Y, Takehara T, Tokushige K, Nakajima A, Yoneda M, Saibara T, Shiota G, Sakaida I, Nakamuta M, Mizuta T, Tsubouchi H, Sugano K, Shimosegawa T.

Hepatol Res. 2015 Apr;45(4):363-77. doi: 10.1111/hepr.12511.

PMID:
25832328
5.

Human neutrophil peptides induce interleukin-8 in intestinal epithelial cells through the P2 receptor and ERK1/2 signaling pathways.

Ibusuki K, Sakiyama T, Kanmura S, Maeda T, Iwashita Y, Nasu Y, Sasaki F, Taguchi H, Hashimoto S, Numata M, Uto H, Tsubouchi H, Ido A.

Int J Mol Med. 2015 Jun;35(6):1603-9. doi: 10.3892/ijmm.2015.2156. Epub 2015 Mar 26.

PMID:
25816245
6.

A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus.

Hiramine S, Sugiyama M, Furusyo N, Uto H, Ido A, Tsubouchi H, Watanabe H, Ueno Y, Korenaga M, Murata K, Masaki N, Hayashi J, Thomas DL, Mizokami M.

J Gastroenterol. 2015 Mar 5. [Epub ahead of print]

PMID:
25735432
7.

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Watanabe S, Hashimoto E, Ikejima K, Uto H, Ono M, Sumida Y, Seike M, Takei Y, Takehara T, Tokushige K, Nakajima A, Yoneda M, Saibara T, Shiota G, Sakaida I, Nakamuta M, Mizuta T, Tsubouchi H, Sugano K, Shimosegawa T.

J Gastroenterol. 2015 Apr;50(4):364-77. doi: 10.1007/s00535-015-1050-7. Epub 2015 Feb 24.

PMID:
25708290
8.

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan.

Sakaida I, Nakajima K, Okita K, Hori M, Izumi T, Sakurai M, Shibasaki Y, Tachikawa S, Tsubouchi H, Oka H, Kobayashi H.

J Gastroenterol. 2015 Feb 18. [Epub ahead of print]

PMID:
25689936
9.

Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial.

Matsumoto N, Miki K, Tsubouchi H, Sakamoto A, Arimura Y, Yanagi S, Iiboshi H, Yoshida M, Souma R, Ishimoto H, Yamamoto Y, Yatera K, Yoshikawa M, Sagara H, Iwanaga T, Mukae H, Maekura R, Kimura H, Nakazato M, Kangawa K.

Lung. 2015 Apr;193(2):239-47. doi: 10.1007/s00408-015-9685-y. Epub 2015 Jan 30.

PMID:
25634352
10.

Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.

Yoshimine Y, Uto H, Kumagai K, Mawatari S, Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, Tamai T, Moriuchi A, Tsubouchi H, Ido A.

Oncol Rep. 2015 Apr;33(4):1657-66. doi: 10.3892/or.2015.3745. Epub 2015 Jan 21.

PMID:
25607821
11.

Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors for postoperative stricture.

Funakawa K, Uto H, Sasaki F, Nasu Y, Mawatari S, Arima S, Nakazawa J, Taguchi H, Hashimoto S, Kanmura S, Setoyama H, Numata M, Tsubouchi H, Ido A.

Medicine (Baltimore). 2015 Jan;94(1):e373. doi: 10.1097/MD.0000000000000373.

PMID:
25569662
12.

Clinical profiles of patients with primary sclerosing cholangitis in the elderly.

Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H.

J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):230-6. doi: 10.1002/jhbp.194. Epub 2014 Nov 19.

PMID:
25408495
13.

Growth factor-eluting cochlear implant electrode: impact on residual auditory function, insertional trauma, and fibrosis.

Kikkawa YS, Nakagawa T, Ying L, Tabata Y, Tsubouchi H, Ido A, Ito J.

J Transl Med. 2014 Oct 4;12:280. doi: 10.1186/s12967-014-0280-4.

14.

Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.

Tsubouchi H, Yanagi S, Miura A, Mogami S, Yamada C, Iizuka S, Hattori T, Nakazato M.

Nutr Res. 2014 Oct;34(10):876-85. doi: 10.1016/j.nutres.2014.08.014. Epub 2014 Sep 3.

PMID:
25270999
15.

Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.

Tsubouchi H, Yanagi S, Miura A, Matsumoto N, Kangawa K, Nakazato M.

Eur J Pharmacol. 2014 Nov 15;743:1-10. doi: 10.1016/j.ejphar.2014.09.025. Epub 2014 Sep 23.

PMID:
25257464
16.

Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.

Tanaka A, Hirohara J, Nakanuma Y, Tsubouchi H, Takikawa H.

J Gastroenterol. 2015 Jun;50(6):675-82. doi: 10.1007/s00535-014-0998-z. Epub 2014 Sep 20.

PMID:
25239675
17.

Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis.

Nakamura M, Kondo H, Tanaka A, Komori A, Ito M, Yamamoto K, Ohira H, Zeniya M, Hashimoto E, Honda M, Kaneko S, Ueno Y, Kikuchi K, Shimoda S, Harada K, Arai K, Miyake Y, Abe M, Taniai M, Saibara T, Sakisaka S, Takikawa H, Onji M, Tsubouchi H, Nakanuma Y, Ishibashi H.

Hepatol Res. 2015 Aug;45(8):846-55. doi: 10.1111/hepr.12423. Epub 2014 Dec 11.

PMID:
25220608
18.

Horizontal transmission of de novo hepatitis B between spouses: A case report.

Mawatari S, Uto H, Moriuchi A, Tabu K, Muromachi K, Tabu E, Oda K, Imanaka D, Oshige A, Nakazawa J, Kumagai K, Tamai T, Okamoto H, Tsubouchi H, Ido A.

Hepatol Res. 2015 Aug;45(8):933-938. doi: 10.1111/hepr.12422. Epub 2014 Oct 14.

PMID:
25211282
19.

Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.

Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T.

Ther Apher Dial. 2014 Dec;18(6):603-11. doi: 10.1111/1744-9987.12189. Epub 2014 Sep 4.

PMID:
25196061
20.

Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan.

Oda K, Uto H, Kumagai K, Ido A, Kusumoto K, Shimoda K, Hayashi K, Stuver SO, Tanaka Y, Nishida N, Tokunaga K, Tsubouchi H.

J Med Virol. 2014 Nov;86(11):1877-85. doi: 10.1002/jmv.24037. Epub 2014 Aug 7.

PMID:
25100136
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk